ODI Pharma AB Reports Earnings Results for the First Quarter Ended September 30, 2021
November 25, 2021 at 11:10 am EST
ODI Pharma AB (publ) reported earnings results for the first quarter ended September 30, 2021. For the first quarter, the company reported revenue was SEK 0.000317 million compared to SEK 0.000419 million a year ago. Net loss was SEK 1.18 million compared to SEK 1.28 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.08 a year ago.